Reuters -- European health regulators recommended on Thursday restricting the use of Cephalon’s (CEPH.O) sleep disorder drug Provigil for treating narcolepsy only, over concerns that risks may outweigh the benefits of the medicine in other uses.
Reuters -- European health regulators recommended on Thursday restricting the use of Cephalon’s (CEPH.O) sleep disorder drug Provigil for treating narcolepsy only, over concerns that risks may outweigh the benefits of the medicine in other uses.